Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 94

1.

Upgrading Therapy Strategy Improves Pregnancy Outcome in Antiphospholipid Syndrome: A Cohort Management Study.

Hoxha A, Favaro M, Calligaro A, Del Ross T, Ruffatti AT, Infantolino C, Tonello M, Mattia E, Ruffatti A.

Thromb Haemost. 2019 Oct 21. doi: 10.1055/s-0039-1697665. [Epub ahead of print]

PMID:
31634958
2.

Complement activation in the plasma and placentas of women with different subsets of antiphospholipid syndrome.

Scambi C, Ugolini S, Tonello M, Bortolami O, De Franceschi L, Castagna A, Lotti V, Corbella M, Raffaelli R, Caramaschi P, Mattia E, Biasi D, Ruffatti A.

Am J Reprod Immunol. 2019 Sep 3:e13185. doi: 10.1111/aji.13185. [Epub ahead of print]

PMID:
31479579
3.

Colic and rectal tumors with peritoneal metastases treated with cytoreductive surgery and HIPEC: One homogeneous condition or two different diseases? A systematic review and meta-analysis.

Tonello M, Sommariva A, Pirozzolo G, Mattara G, Pilati P.

Eur J Surg Oncol. 2019 Nov;45(11):2003-2008. doi: 10.1016/j.ejso.2019.06.020. Epub 2019 Jun 12. Review.

PMID:
31217079
4.

IgG phosphatidylserine/prothrombin antibodies as a risk factor of thrombosis in antiphospholipid antibody carriers.

Tonello M, Mattia E, Favaro M, Del Ross T, Calligaro A, Salvan E, Hoxha A, Fedrigo M, Ruffatti A.

Thromb Res. 2019 May;177:157-160. doi: 10.1016/j.thromres.2019.03.006. Epub 2019 Mar 8.

PMID:
30903876
5.

First Report of the Italian Registry on Immune-Mediated Congenital Heart Block (Lu.Ne Registry).

Fredi M, Andreoli L, Bacco B, Bertero T, Bortoluzzi A, Breda S, Cappa V, Ceccarelli F, Cimaz R, De Vita S, Di Poi E, Elefante E, Franceschini F, Gerosa M, Govoni M, Hoxha A, Lojacono A, Marozio L, Mathieu A, Meroni PL, Minniti A, Mosca M, Muscarà M, Padovan M, Piga M, Priori R, Ramoni V, Ruffatti A, Tani C, Tonello M, Trespidi L, Zatti S, Calza S, Tincani A, Brucato A.

Front Cardiovasc Med. 2019 Feb 28;6:11. doi: 10.3389/fcvm.2019.00011. eCollection 2019.

6.

Molecular characterization of "sessile serrated" adenoma to carcinoma transition in six early colorectal cancers.

Cappellesso R, Lo Mele M, Munari G, Rosa-Rizzotto E, Guido E, De Lazzari F, Pilati P, Tonello M, Farinati F, Realdon S, Fassan M, Rugge M.

Pathol Res Pract. 2019 May;215(5):957-962. doi: 10.1016/j.prp.2019.02.001. Epub 2019 Feb 3.

PMID:
30738693
7.

Iterative Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Recurrent Peritoneal Metastases.

Sommariva A, Tonello M, Cona C, Pilati P, Rossi CR.

Anticancer Res. 2018 Sep;38(9):5521-5524. doi: 10.21873/anticanres.12886.

PMID:
30194211
8.

Catastrophic antiphospholipid syndrome: Lessons from 14 cases successfully treated in a single center. A narrative report.

Ruffatti A, De Silvestro G, Marson P, Tonello M, Calligaro A, Favaro M, Del Ross T, Hoxha A, Mattia E, Pengo V.

J Autoimmun. 2018 Sep;93:124-130. doi: 10.1016/j.jaut.2018.07.001. Epub 2018 Jul 7.

PMID:
30146007
9.

Antiphosphatidylserine/prothrombin Antibodies in Antiphospholipid Syndrome with Intrauterine Growth Restriction and Preeclampsia.

Canti V, Del Rosso S, Tonello M, Lucianò R, Hoxha A, Coletto LA, Vaglio Tessitore I, Rosa S, Manfredi AA, Castiglioni MT, Ruffatti A, Rovere-Querini P.

J Rheumatol. 2018 Aug;45(9):1263-1272. doi: 10.3899/jrheum.170751. Epub 2018 Jul 15.

PMID:
30008452
10.

Clinical value of anti-domain I-β2Glycoprotein 1 antibodies in antiphospholipid antibody carriers. A single centre, prospective observational follow-up study.

Tonello M, Mattia E, Del Ross T, Favaro M, Calligaro A, Hoxha A, Bison E, Pengo V, Ruffatti A.

Clin Chim Acta. 2018 Oct;485:74-78. doi: 10.1016/j.cca.2018.06.037. Epub 2018 Jun 25.

PMID:
29953850
11.

Peritoneal carcinomatosis arising from rectal or colonic adenocarcinoma treated with cytoreductive surgery (CRS) hyperthermic intraperitoneal chemotherapy (HIPEC): two different diseases.

Tonello M, Ortega-Perez G, Alonso-Casado O, Torres-Mesa P, Guiñez G, Gonzalez-Moreno S.

Clin Transl Oncol. 2018 Oct;20(10):1268-1273. doi: 10.1007/s12094-018-1857-9. Epub 2018 Apr 17.

PMID:
29667123
12.

Clinical and laboratory characteristics of isolated lupus anticoagulants.

Mattia E, Tonello M, Del Ross T, Zerbinati P, Campello E, Simioni P, Ruffatti A.

Thromb Res. 2018 May;165:51-53. doi: 10.1016/j.thromres.2018.03.008. Epub 2018 Mar 13. No abstract available.

PMID:
29567587
13.

Effect of Additional Treatments Combined with Conventional Therapies in Pregnant Patients with High-Risk Antiphospholipid Syndrome: A Multicentre Study.

Ruffatti A, Tonello M, Hoxha A, Sciascia S, Cuadrado MJ, Latino JO, Udry S, Reshetnyak T, Costedoat-Chalumeau N, Morel N, Marozio L, Tincani A, Andreoli L, Haladyj E, Meroni PL, Gerosa M, Alijotas-Reig J, Tenti S, Mayer-Pickel K, Simchen MJ, Bertero MT, De Carolis S, Ramoni V, Mekinian A, Grandone E, Maina A, Serrano F, Pengo V, Khamashta MA.

Thromb Haemost. 2018 Apr;118(4):639-646. doi: 10.1055/s-0038-1632388. Epub 2018 Feb 28.

14.

Beyond thrombosis: Anti-β2GPI domain 1 antibodies identify late pregnancy morbidity in anti-phospholipid syndrome.

Chighizola CB, Pregnolato F, Andreoli L, Bodio C, Cesana L, Comerio C, Gerosa M, Grossi C, Kumar R, Lazzaroni MG, Mahler M, Mattia E, Nalli C, Norman GL, Raimondo MG, Ruffatti A, Tonello M, Trespidi L, Tincani A, Borghi MO, Meroni PL.

J Autoimmun. 2018 Jun;90:76-83. doi: 10.1016/j.jaut.2018.02.002. Epub 2018 Feb 14.

PMID:
29454510
15.

Circulating microparticles in pregnant patients with primary anti-phospholipid syndrome: an exploratory study.

Campello E, Radu CM, Tonello M, Kuzenko A, Bulato C, Hoxha A, Mattia E, Spiezia L, Ruffatti A, Simioni P.

Scand J Rheumatol. 2018 Nov;47(6):501-504. doi: 10.1080/03009742.2017.1372518. Epub 2018 Jan 8. No abstract available.

PMID:
29308695
16.

Detection of autoantibodies to the p200-epitope of SSA/Ro52 antigen. A comparison of two laboratory assays.

Mattia E, Hoxha A, Tonello M, Favaro M, Del Ross T, Calligaro A, Ghirardello A, Ruffatti A.

Clin Chem Lab Med. 2018 May 24;56(6):927-932. doi: 10.1515/cclm-2017-0704.

PMID:
29303768
17.

Anti-dermatophyte activity of Leguminosae plants from Southern Brazil with emphasis on Mimosa pigra (Leguminosae).

de Morais CB, Scopel M, Pedrazza GPR, da Silva FK, Dalla Lana DF, Tonello ML, Miotto STS, Machado MM, De Oliveira LFS, Fuentefria AM, Zuanazzi JAS.

J Mycol Med. 2017 Dec;27(4):530-538. doi: 10.1016/j.mycmed.2017.07.006. Epub 2017 Aug 16.

PMID:
28822705
18.

Longterm Outcome of Patients with Primary Antiphospholipid Syndrome: A Retrospective Multicenter Study.

Taraborelli M, Reggia R, Dall'Ara F, Fredi M, Andreoli L, Gerosa M, Hoxha A, Massaro L, Tonello M, Costedoat-Chalumeau N, Cacoub P, Franceschini F, Meroni PL, Piette JC, Ruffatti A, Valesini G, Harris EN, Tincani A.

J Rheumatol. 2017 Aug;44(8):1165-1172. doi: 10.3899/jrheum.161364. Epub 2017 Jun 1.

PMID:
28572466
19.

Low titer, isolated anti Ro/SSA 60 kd antibodies is correlated with positive pregnancy outcomes in women at risk of congenital heart block.

Tonello M, Hoxha A, Mattia E, Zambon A, Visentin S, Cerutti A, Ghirardello A, Milanesi O, Ruffatti A.

Clin Rheumatol. 2017 May;36(5):1155-1160. doi: 10.1007/s10067-017-3572-2. Epub 2017 Feb 15.

PMID:
28204891
20.

Antiphosphatidylserine/prothrombin antibodies as biomarkers to identify severe primary antiphospholipid syndrome.

Hoxha A, Mattia E, Tonello M, Grava C, Pengo V, Ruffatti A.

Clin Chem Lab Med. 2017 May 1;55(6):890-898. doi: 10.1515/cclm-2016-0638.

PMID:
27816952
21.

Effects of physical exercise on musculoskeletal disorders, stress and quality of life in workers.

Serra MVGB, Camargo PR, Zaia JE, Tonello MGM, Quemelo PRV.

Int J Occup Saf Ergon. 2018 Mar;24(1):62-67. doi: 10.1080/10803548.2016.1234132. Epub 2016 Oct 6.

PMID:
27690286
22.

Long-term use of hydroxychloroquine reduces antiphospholipid antibodies levels in patients with primary antiphospholipid syndrome.

Nuri E, Taraborelli M, Andreoli L, Tonello M, Gerosa M, Calligaro A, Argolini LM, Kumar R, Pengo V, Meroni PL, Ruffatti A, Tincani A.

Immunol Res. 2017 Feb;65(1):17-24. doi: 10.1007/s12026-016-8812-z.

PMID:
27406736
23.

Additional Treatments for High-Risk Obstetric Antiphospholipid Syndrome: a Comprehensive Review.

Ruffatti A, Hoxha A, Favaro M, Tonello M, Colpo A, Cucchini U, Banzato A, Pengo V.

Clin Rev Allergy Immunol. 2017 Aug;53(1):28-39. doi: 10.1007/s12016-016-8571-6. Review.

PMID:
27342460
24.

Apheresis and intravenous immunoglobulins used in addition to conventional therapy to treat high-risk pregnant antiphospholipid antibody syndrome patients. A prospective study.

Ruffatti A, Favaro M, Hoxha A, Zambon A, Marson P, Del Ross T, Calligaro A, Tonello M, Nardelli GB.

J Reprod Immunol. 2016 Jun;115:14-9. doi: 10.1016/j.jri.2016.03.004. Epub 2016 Mar 29.

PMID:
27088752
25.

Maternal autoantibody profiles at risk for autoimmune congenital heart block: a prospective study in high-risk patients.

Tonello M, Ruffatti A, Favaro M, Tison T, Del Ross T, Calligaro A, Hoxha A, Mattia E, Punzi L.

Lupus Sci Med. 2016 Mar 24;3(1):e000129. doi: 10.1136/lupus-2015-000129. eCollection 2016.

26.

The clinical relevance of early anti-adalimumab antibodies detection in rheumatoid arthritis, ankylosing spondylitis and psoriatic arthritis: A prospective multicentre study.

Hoxha A, Calligaro A, Tonello M, Ramonda R, Carletto A, Paolazzi G, Bortolotti R, Del Ross T, Grava C, Boaretto M, Favaro M, Teghil V, Ruffatti A, Punzi L.

Joint Bone Spine. 2016 Mar;83(2):167-71. doi: 10.1016/j.jbspin.2015.04.020. Epub 2015 Dec 29.

PMID:
26750762
27.

Apheresis in high risk antiphospholipid syndrome pregnancy and autoimmune congenital heart block.

Ruffatti A, Favaro M, Brucato A, Ramoni V, Facchinetti M, Tonello M, Del Ross T, Calligaro A, Hoxha A, Grava C, De Silvestro G.

Transfus Apher Sci. 2015 Dec;53(3):269-78. doi: 10.1016/j.transci.2015.11.006. Epub 2015 Nov 25. Review.

PMID:
26626966
28.

The clinical relevance of the IgM isotype of antiphospholipid antibodies in the vascular antiphospholipid syndrome.

Del Ross T, Ruffatti A, Cuffaro S, Tonello M, Calligaro A, Favaro M, Facchinetti M, Hoxha A, Punzi L.

Thromb Res. 2015 Nov;136(5):883-6. doi: 10.1016/j.thromres.2015.08.019. Epub 2015 Sep 5.

PMID:
26410418
29.

Antibodies to Domain 4/5 (Dm4/5) of β2-Glycoprotein 1 (β2GP1) in different antiphospholipid (aPL) antibody profiles.

Pengo V, Ruffatti A, Tonello M, Hoxha A, Bison E, Denas G, Padayattil Jose S, Zoppellaro G, Bracco A, Banzato A.

Thromb Res. 2015 Jul;136(1):161-3. doi: 10.1016/j.thromres.2015.04.031. Epub 2015 May 1.

PMID:
25959581
30.

Detection of IgG anti-Domain I beta2 Glycoprotein I antibodies by chemiluminescence immunoassay in primary antiphospholipid syndrome.

Meneghel L, Ruffatti A, Gavasso S, Tonello M, Mattia E, Spiezia L, Tormene D, Hoxha A, Fedrigo M, Simioni P.

Clin Chim Acta. 2015 Jun 15;446:201-5. doi: 10.1016/j.cca.2015.04.033. Epub 2015 Apr 30.

PMID:
25935129
31.

A contribution to detection of anticardiolipin and anti-β2glycoprotein I antibodies: Comparison between a home-made ELISA and a fluorescence enzyme immunoassay.

Mattia E, Ruffatti A, Meneghel L, Tonello M, Faggian D, Hoxha A, Fedrigo M, Punzi L, Plebani M.

Clin Chim Acta. 2015 Jun 15;446:93-6. doi: 10.1016/j.cca.2015.04.012. Epub 2015 Apr 17.

PMID:
25892672
32.

Plasma exchange effectively removes 52- and 60-kDa anti-Ro/SSA and anti-La/SSB antibodies in pregnant women with congenital heart block.

Tonello M, Ruffatti A, Marson P, Tison T, Marozio L, Hoxha A, De Silvestro G, Punzi L.

Transfusion. 2015 Jul;55(7):1782-6. doi: 10.1111/trf.13046. Epub 2015 Mar 30.

PMID:
25825254
33.

The clinical performance of a chemiluminescent immunoassay in detecting anti-cardiolipin and anti-β2 glycoprotein I antibodies. A comparison with a homemade ELISA method.

Meneghel L, Ruffatti A, Gavasso S, Tonello M, Mattia E, Spiezia L, Campello E, Hoxha A, Fedrigo M, Punzi L, Simioni P.

Clin Chem Lab Med. 2015 Jun;53(7):1083-9. doi: 10.1515/cclm-2014-0925.

PMID:
25720075
34.

Antiphospholipid syndrome: antibodies to Domain 1 of β2-glycoprotein 1 correctly classify patients at risk.

Pengo V, Ruffatti A, Tonello M, Cuffaro S, Banzato A, Bison E, Denas G, Padayattil Jose S.

J Thromb Haemost. 2015 May;13(5):782-7. doi: 10.1111/jth.12865. Epub 2015 Mar 5.

35.

Relationship between antiphosphatidylserine/prothrombin and conventional antiphospholipid antibodies in primary antiphospholipid syndrome.

Hoxha A, Ruffatti A, Mattia E, Meneghel L, Tonello M, Salvan E, Pengo V, Punzi L.

Clin Chem Lab Med. 2015 Jul;53(8):1265-70. doi: 10.1515/cclm-2014-1129.

PMID:
25562605
36.

IgA anticardiolipin and IgA anti-β2 glycoprotein I antibody positivity determined by fluorescence enzyme immunoassay in primary antiphospholipid syndrome.

Mattia E, Ruffatti A, Tonello M, Meneghel L, Robecchi B, Pittoni M, Gallo N, Salvan E, Teghil V, Punzi L, Plebani M.

Clin Chem Lab Med. 2014 Sep;52(9):1329-33. doi: 10.1515/cclm-2014-0039.

PMID:
24651022
37.

Confirmation of initial antiphospholipid antibody positivity depends on the antiphospholipid antibody profile.

Pengo V, Ruffatti A, Del Ross T, Tonello M, Cuffaro S, Hoxha A, Banzato A, Bison E, Denas G, Bracco A, Padayattil Jose S.

J Thromb Haemost. 2013 Aug;11(8):1527-31. doi: 10.1111/jth.12264.

38.

Platelet and endothelial activation in catastrophic and quiescent antiphospholipid syndrome.

Bontadi A, Ruffatti A, Falcinelli E, Giannini S, Marturano A, Tonello M, Hoxha A, Pengo V, Punzi L, Momi S, Gresele P.

Thromb Haemost. 2013 May;109(5):901-8. doi: 10.1160/TH12-03-0212. Epub 2013 Apr 4.

PMID:
23572134
39.

Treatment of 139 pregnancies in antiphospholipid-positive women not fulfilling criteria for antiphospholipid syndrome: a retrospective study.

Del Ross T, Ruffatti A, Visentin MS, Tonello M, Calligaro A, Favaro M, Hoxha A, Punzi L.

J Rheumatol. 2013 Apr;40(4):425-9. doi: 10.3899/jrheum.120576. Epub 2013 Feb 15.

PMID:
23418380
40.

Prognosis of scleroderma renal crisis: a long-term observational study.

Cozzi F, Marson P, Cardarelli S, Favaro M, Tison T, Tonello M, Pigatto E, De Silvestro G, Punzi L, Doria A.

Nephrol Dial Transplant. 2012 Dec;27(12):4398-403. doi: 10.1093/ndt/gfs317. Epub 2012 Aug 1.

PMID:
22859795
41.

Hypertension negatively affects the pregnancy outcome in patients with antiphospholipid syndrome.

Canti V, Maggio L, Ramirez GA, Locatelli A, Cozzolino S, Ramoni V, Ruffatti A, Tonello M, Valsecchi L, Rosa S, Inversetti A, Manfredi AA, Sabbadini MG, Castiglioni MT, Rovere-Querini P.

Lupus. 2012 Jun;21(7):810-2. doi: 10.1177/0961203312441269.

PMID:
22635241
42.

Antiphosphatidylserine/prothrombin antibodies in primary antiphospholipid syndrome.

Hoxha A, Ruffatti A, Tonello M, Bontadi A, Salvan E, Banzato A, Pengo V, Punzi L.

Lupus. 2012 Jun;21(7):787-9. doi: 10.1177/0961203312441983.

PMID:
22635234
43.

Risk-based secondary prevention of obstetric antiphospholipid syndrome.

Ruffatti A, Calligaro A, Del Ross T, Favaro M, Tonello M, Banzato A, Punzi L, Pengo V.

Lupus. 2012 Jun;21(7):741-3. doi: 10.1177/0961203312446388.

PMID:
22635219
44.

Surgery for primary cardiac tumors in children: early and late results in a multicenter European Congenital Heart Surgeons Association study.

Padalino MA, Vida VL, Boccuzzo G, Tonello M, Sarris GE, Berggren H, Comas JV, Di Carlo D, Di Donato RM, Ebels T, Hraska V, Jacobs JP, Gaynor JW, Metras D, Pretre R, Pozzi M, Rubay J, Sairanen H, Schreiber C, Maruszewski B, Basso C, Stellin G.

Circulation. 2012 Jul 3;126(1):22-30. doi: 10.1161/CIRCULATIONAHA.111.037226. Epub 2012 May 24.

PMID:
22626745
45.

Plasma exchange and immunoadsorption effectively remove antiphospholipid antibodies in pregnant patients with antiphospholipid syndrome.

Bontadi A, Ruffatti A, Marson P, Tison T, Tonello M, Hoxha A, De Silvestro G, Punzi L.

J Clin Apher. 2012;27(4):200-4. doi: 10.1002/jca.21229. Epub 2012 Apr 24.

PMID:
22532158
46.

In vitro effect of anti-β₂ glycoprotein I antibodies on P-selectin expression, a marker of platelet activation.

Bontadi A, Ruffatti A, Giannini S, Falcinelli E, Tonello M, Hoxha A, Gresele P, Punzi L.

Reumatismo. 2012 Mar 19;64(1):35-9. doi: 10.4081/reumatismo.2012.35.

PMID:
22472781
47.

A 13 kg intra-abdominal mass: a case of mesenteric fibromatosis.

Menegazzo M, Tonello M, Bardini R.

Updates Surg. 2013 Sep;65(3):237-40. doi: 10.1007/s13304-012-0143-6. Epub 2012 Mar 13.

PMID:
22410827
48.

The clinical significance of autoantibodies directed against prothrombin in primary antiphospholipid syndrome.

Hoxha A, Ruffatti A, Pittoni M, Bontadi A, Tonello M, Salvan E, Plebani M, Punzi L.

Clin Chim Acta. 2012 May 18;413(9-10):911-3. doi: 10.1016/j.cca.2012.02.004. Epub 2012 Feb 12.

PMID:
22349599
49.

Incidence of a first thromboembolic event in asymptomatic carriers of high-risk antiphospholipid antibody profile: a multicenter prospective study.

Pengo V, Ruffatti A, Legnani C, Testa S, Fierro T, Marongiu F, De Micheli V, Gresele P, Tonello M, Ghirarduzzi A, Bison E, Denas G, Banzato A, Padayattil Jose S, Iliceto S.

Blood. 2011 Oct 27;118(17):4714-8. doi: 10.1182/blood-2011-03-340232. Epub 2011 Jul 15.

PMID:
21765019
50.

Risk factors for pregnancy failure in patients with anti-phospholipid syndrome treated with conventional therapies: a multicentre, case-control study.

Ruffatti A, Tonello M, Visentin MS, Bontadi A, Hoxha A, De Carolis S, Botta A, Salvi S, Nuzzo M, Rovere-Querini P, Canti V, Mosca M, Mitic G, Bertero MT, Pengo V, Boffa MC, Tincani A.

Rheumatology (Oxford). 2011 Sep;50(9):1684-9. doi: 10.1093/rheumatology/ker139. Epub 2011 Jun 7.

PMID:
21652586

Supplemental Content

Loading ...
Support Center